Nav: Home

Zika vaccines offer full protection to monkeys

August 04, 2016

Analysis of three types of Zika vaccines reveal that they are effective at protecting rhesus monkeys from the virus, a new study reports. Whereas some similar techniques and vaccines have been tested in mice, monkeys are a much better model to determine how vaccines will work in humans. Zika has been causally associated with fetal microcephaly, intrauterine growth retardation, and other birth malformations in humans. A preventative vaccine is poised as one of the best ways to minimize the spread of the virus and its detrimental effects. Previously, researchers including Peter Abbink and Dan Barouch had reported that both a DNA vaccine and a purified inactivated virus (PIV) vaccine were effective at protecting mice from the virus. Now, Abbink et al. report the efficacy of the PIV virus in 16 rhesus monkeys, eight of which were given sham vaccines as controls. All PIV vaccinated animals developed Zika-specific binding and neutralizing antibodies two weeks following immunization, and were completely protected from Zika when exposed to the virus. When the researchers harvested antibodies from Zika-PIV vaccinated monkeys and transferred them to mice and monkeys, a technique called adoptive transfer, these animals also were protected against Zika virus, as long as therapeutically sufficient antibody titers were transferred. The researchers also tested a DNA vaccine and a recombinant adenovirus (Ad) vector expressing the Zika pre-membrane and envelope protein. These two vaccines also raised antibody responses and provided full protection to monkeys, and the Ad vector even protected after a single immunization. Across all three platforms, no adverse effects were reported.
-end-


American Association for the Advancement of Science

Related Vaccines Articles:

Understanding T cell activation could lead to new vaccines
Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.
Vaccines do work for pandemic flu, says study
Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalized as a result of the illness, a study led by academics at the University of Nottingham has found.
Research could lead to better vaccines and new antivirals
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new regulator of the innate immune response -- the immediate, natural immune response to foreign invaders.
Toward opioid vaccines that can help prevent overdose fatalities
In 2014, the number of deaths from opioid overdoses in the US jumped to its highest level on record.
New, more effective strategy for producing flu vaccines
A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines that protect people from influenza B.
A method for storing vaccines at room temperature
Several simple and inexpensive techniques make it possible to store antiviral-vaccines at room temperature for several months.
Engineers design programmable RNA vaccines
MIT engineers have designed programmable RNA vaccines that could be rapidly manufactured and deployed.
Zika vaccines protect mice from infection
A single dose of either of two experimental Zika vaccines fully protected mice challenged with Zika virus four or eight weeks after receiving the inoculations.
Can we hypercharge vaccines?
Researchers at Boston Children's Hospital report that a fatty chemical naturally found in damaged tissues can induce an unexpected kind of immune response, causing immune cells to go into a 'hyperactive' state that is highly effective at rallying infection-fighting T-cells.
Vaccines: Don't leave home without them
While Americans should be fully vaccinated before travelling internationally to avoid infection with highly contagious diseases such as measles and hepatitis A, many are not, suggest two studies being presented at IDWeek 2015™.

Related Vaccines Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".